Dagher Ibrahim B. has filed 3 insider transactions across 1 company since July 2024.
Most recent transaction: a grant/award of 225000 shares of BRAINSTORM CELL THERAPEUTICS INC. ($BCLI) on February 26, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Dagher Ibrahim B. | Director | A | Stock Option (Right to Buy) | 225000 | $0.70 | 225,000.0000 | 9,268,976 | 9999.99% | 2.43% |
| Jan. 1, 2025 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Dagher Ibrahim B. | Chief Medical Officer | A | Common Stock | 50000 | $0.00 | 79,515.0000 | 5,021,798 | 169.41% | 1.00% |
| July 19, 2024 | BRAINSTORM CELL THERAPEUTICS INC. | $BCLI | Dagher Ibrahim B. | Chief Medical Officer | S | Common Stock | 63000 | $0.35 | 190,000.0000 | 4,747,699 | 24.90% | 1.33% |